UFM1 and cancer: In patients with OSCC of T1-2, T1-3, T2-3, T2-4, T3, T3-4, N0, N1-2, N1-3, N2, N2-3 and M0 stages, elevated UFM1 expression was significantly associated with the poorer PFI in cancer patients (Figure 6).